A Meta-Analysis on the Impact of Platinum-Based Adjuvant Treatment on the Outcome of Borderline Ovarian Tumors With Invasive Implants Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, January 21, 2015

A Meta-Analysis on the Impact of Platinum-Based Adjuvant Treatment on the Outcome of Borderline Ovarian Tumors With Invasive Implants



Gynecologic Oncology


The Oncologist first published on January 19, 2015; doi:10.1634/theoncologist.2014-0144
 
 
Borderline ovarian tumors (BOTs) have been a challenge for patients, pathologists, and oncologists. For the group of patients with invasive implants, there is no consensus regarding standard therapy. This meta-analysis examines the benefits, or lack thereof, of platinum-based adjuvant treatment for BOT, showing that at present there is no evidence to support this treatment form.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.